FDA EIR - Novartis Gene Therapies, Inc. - February 15, 2019
FDA EIR for Novartis Gene Therapies, Inc. on February 15, 2019. Product: Other. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA EIR for Novartis Gene Therapies, Inc. on February 15, 2019. Product: Other. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
February 15, 2019
Product Type
Other
ID: f5f81226-4da7-4cdc-91da-5e61e1786be0
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox